Shareholder deadlock at a mid-market pharma manufacturer
Acted for the minority shareholder in a 60/40 deadlock at a Maharashtra-based pharma manufacturer. Negotiated buyout in seven weeks; full report sealed.
Acted for the minority shareholder in a 60/40 deadlock at a Maharashtra-based pharma manufacturer. Negotiated buyout in seven weeks; full report sealed.
Defended a 96-flat society in a redevelopment dispute with a developer over delayed possession. Resolved through structured mediation under the new RERA framework.
Acted for the departing co-founder of a Series-B SaaS firm. Negotiated a clean exit with bounded non-compete and clear IP carve-out.
Recovered outstanding payments owed by a downstream vendor through structured legal notice and pre-arbitral negotiation. No court appearance.
Successfully struck down an over-broad two-year non-solicit covenant before the appellate tribunal. Set a useful internal precedent for the chambers.